Perater, Esmeraldo, Jr. O.

HRN: 28-85-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2026
CO-AMOXICLAV 625MG (TAB)
04/15/2026
04/22/2026
PO
625mg
BID
Abrasions On Left And Right Knee Secondary To RCI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: